NCT02607111View on ClinicalTrials.gov

A New Anticoagulation Method Using Dalteparin in Quotidian and Nocturnal Home Hemodialysis Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

July 31, 2018

Study Completion Date

July 30, 2018

Conditions
Kidney Failure
Interventions
DRUG

Dalteparin

Trial Locations (1)

N6A 5A5

London Health Sciences Centre, London

All Listed Sponsors
lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

NCT02607111 - A New Anticoagulation Method Using Dalteparin in Quotidian and Nocturnal Home Hemodialysis Patients | Biotech Hunter | Biotech Hunter